Phibro Animal Health Corp. has signed a long-term lease renewal for its global headquarters at the Glenpointe complex in Teaneck, according to property owner Alfred Sanzari Enterprises.
The international company leases 49,577 square feet at the property, at 300/400/500 Frank W. Burr Blvd., the property developer, owner and manager said in a news release.
“For companies looking to do business in the New York City metropolitan area, there is no place like Glenpointe,” Carolina Gutierrez, manager, leasing and marketing, for Sanzari, said in a prepared statement. “Seamlessly blending Class A office space with a robust amenity package and an unparalleled location, Glenpointe stands alone as the place to be for large, growing companies like Phibro Animal Health Corp. We are honored that they have chosen to maintain their headquarters at Glenpointe, and look forward to continuing to build on our relationship over the years to come.”
Newmark’s David Simson, Jeff Schotz, Peter Rossi, Dan Reider and Peter Kasparian represented Sanzari in the transaction. JLL’s Susan Mason and Tom Reilly represented Phibro.
“Choosing to continue to call Glenpointe home was the only choice in our eyes when it came time to make a long-term real estate decision for our company’s headquarters,” Phibro Chief Financial Officer Damian Finio said in a statement. “Throughout our time at the campus, it has consistently evolved with our growing business’s needs, and we are confident it will remain the ideal home for Phibro Animal Health Corp. as we look toward an exciting future.”